Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-19

Clinical Trial Update: Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes salvage chemotherapy regimens being studied for poor-prognosis germ cell tumors in Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Germ Cell Tumor | Phase 1, Phase 2 | Status: UNKNOWN